Personalize Cancer Treatment for 50 Kids

by Think Cure!


ThinkCure!: New six-gene chips can determine a child's response to treatment by testing their blood or bone marrow. This lets doctors personalize treatment, resulting in more kids beating cancer.

total raised
monthly donors


Children who are facing a recent cancer diagnosis will benefit from these new gene-chips. Doctors can predict each child's response to treatment, which means that the kids have a higher likelihood of beating their cancer through the most effective treatment possible.


ThinkCure! funds research and treatment projects at City of Hope and Childrens Hospital LA that use advanced, collaborative techniques like these gene-chip technologies to predict how each patient will respond to different types of cancer treatment.

Long-Term Impact

ThinkCure! Our aim is to find cures for cancers in our lifetime, and quickly. We want to continue to reduce the number of children who die of cancer, here in America and around the globe.

Additional Documentation

This project has provided additional documentation in a Microsoft Word file (projdoc.doc).


Speeding Cures to Patients at City of Hope

Organization Information

Think Cure!

Location: Los Angeles, CA - USA
Website: http:/​/​
Sarah Gallagher
Project Leader:
Sarah Gallagher
Project Leader
Los Angeles, CA United States

Funded Project!

Combined with other sources of funding, this project raised enough money to fund the outlined activities and is no longer accepting donations.

Still want to help?

Find another project in United States or in Health that needs your help.
Find a Project

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence


Woman Holding a Gift Card
Gift Cards

Young Girl with a Bicycle

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.